Literature DB >> 21487353

Cuba's Biotechnology Revolution.

Debra Evenson.   

Abstract

As a result of accelerated training of scientists and engineers beginning in the 1960s and substantial state investment since the 1980s calculated at about USD$1 billion,[1] Cuban biotechnology has become a major player in the Cuban economy and successfully established its place in the global market. According to a World Bank report, Cuba has the capacity to meet about 80% of its domestic demand for prescription drugs and had achieved annual biotech exports of around USD$100 million in the 1990s.[2] A recent Ernst & Young report puts exports of biotech products at USD$300 million in 2005.

Year:  2007        PMID: 21487353

Source DB:  PubMed          Journal:  MEDICC Rev        ISSN: 1527-3172            Impact factor:   0.583


  3 in total

1.  The curious case of Cuba.

Authors:  C William Keck; Gail A Reed
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

2.  Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.

Authors:  Rachel Evans; Kelvin Lee; Paul K Wallace; Mary Reid; Jason Muhitch; Askia Dozier; Circe Mesa; Patricia L Luaces; Orestes Santos-Morales; Adrienne Groman; Carlos Cedeno; Aileen Cinquino; Daniel T Fisher; Igor Puzanov; Mateusz Opyrchal; Christos Fountzilas; Tong Dai; Marc Ernstoff; Kristopher Attwood; Alan Hutson; Candace Johnson; Zaima Mazorra; Danay Saavedra; Kalet Leon; Agustin Lage; Tania Crombet; Grace K Dy
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

3.  The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico.

Authors:  Dante Israel León-de la O; Halla Thorsteinsdóttir; José Víctor Calderón-Salinas
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.